Emerging Technologies in Continuous IOP Monitoring

Wearable and implantable devices offer new data on pressure variability, though barriers to routine use persist.

Category	Detail
Condition	Glaucoma
Key Mechanisms	Continuous intraocular pressure (IOP) monitoring using wearable and implantable devices.
Target Population	Patients with glaucoma, particularly those with progressive disease despite controlled office readings.
Care Setting	Ophthalmology clinics and home monitoring.

Continuous monitoring technologies can detect diurnal and nocturnal IOP fluctuations.
Wearable contact lens-based sensors (CLBS) and implantable bioMEMS offer new insights into IOP variability.
CLBS like Sensimed Triggerfish provide noninvasive, continuous IOP data during daily activities.
Implantable sensors enable long-term telemetric IOP measurement but require surgical implantation.
Both technologies may improve risk stratification and treatment decision-making in glaucoma management.

Utilize continuous IOP monitoring for comprehensive assessment in glaucoma patients.

Incorporate data from continuous monitoring to guide individualized treatment strategies.

Monitor for potential side effects from CLBS and implantable devices, including transient discomfort and measurement drift.

Patients with glaucoma, especially those with fluctuating IOP or treatment-resistant cases.

Continuous monitoring may reveal previously unrecognized pressure peaks and guide treatment adjustments.

Counsel patients on the temporary nature of side effects from continuous monitoring devices.
Consider both CLBS and implantable sensors for patients requiring detailed IOP assessment.